<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Pregabalin ‚Äì Complete Overview</title>
  <link href="https://fonts.googleapis.com/css2?family=Quicksand:wght@400;600&display=swap" rel="stylesheet">
  <style>
    body {
      font-family: 'Quicksand', sans-serif;
      margin: 0;
      padding: 0;
      background: linear-gradient(to right, #f3faff, #ffffff);
      color: #222;
      line-height: 1.6;
    }
    header {
      background: linear-gradient(to right, #7d7ca6, #3f5d9a);
      color: white;
      padding: 30px 20px 20px;
      text-align: center;
      position: relative;
    }
    .logo-group {
      position: absolute;
      top: 20px;
      left: 20px;
      display: flex;
      flex-wrap: wrap;
      gap: 10px;
      align-items: center;
    }
    .logo-group img {
      height: 50px;
      width: auto;
      background-color: white;
      padding: 4px;
      border-radius: 6px;
    }
    @media (max-width: 600px) {
      .logo-group {
        position: static;
        justify-content: center;
        margin-bottom: 10px;
      }
      header {
        padding-top: 100px;
      }
    }
    h1 {
      margin: 10px 0 5px;
      font-size: 2.5rem;
      font-weight: 600;
    }
    header p {
      margin: 0;
      font-size: 1.1rem;
    }
    main {
      max-width: 900px;
      margin: 0 auto;
      padding: 20px;
    }
    .block {
      background: #ffffff;
      border: 1px solid #ddd;
      border-radius: 8px;
      padding: 20px;
      margin-bottom: 30px;
      box-shadow: 0 4px 10px rgba(0, 0, 0, 0.05);
    }
    h2 {
      color: #3366cc;
      font-weight: 600;
      border-left: 5px solid #3366cc;
      padding-left: 10px;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      margin-top: 10px;
    }
    th, td {
      padding: 10px;
      border: 1px solid #ccc;
      text-align: center;
      vertical-align: top;
    }
    th {
      background: #e8f0fe;
    }
    ul {
      padding-left: 20px;
    }
    img {
      max-width: 100%;
      height: auto;
      border-radius: 6px;
    }
    .formula-img {
      width: 200px;
      margin-top: 10px;
    }
    .brand-img {
      max-width: 90px;
    }
    footer {
      text-align: center;
      padding: 20px;
      background: #f3f6f9;
      color: #555;
      font-size: 0.9rem;
    }
    a {
      color: #3366cc;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
  </style>
</head>
<body>
  <header>
    <div class="logo-group">
      <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSbmJSHgvqOiE2uAzqvDW5vx-lYA2uikxPHVQ&s" alt="UMT Logo">
    </div>
    <h1>üíä Pregabalin</h1>
    <p>Complete Overview</p>
  </header>
  <main>

  <main>


    <div class="block">
      <h2>üß† Introduction</h2>
      <p>Pregabalin is an anticonvulsant and neuropathic pain agent structurally related to gamma-aminobutyric acid (GABA). It is used primarily for epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder.</p>
    </div>

    <div class="block">
      <h2>üß™ Chemical & Structural Information</h2>
      <p><strong>Chemical Formula:</strong> C‚ÇàH‚ÇÅ‚ÇáNO‚ÇÇ</p>
      <img class="formula-img" src="http://www.sielc.com/wp-content/uploads/compounds/Pregabalin.png" alt="Pregabalin Structural Formula">
    </div>

    <div class="block">
      <h2>üè• Therapeutic Category</h2>
      <ul>
        <li>Anticonvulsant</li>
        <li>Neuropathic pain agent</li>
        <li>Anxiolytic adjunct</li>
      </ul>
    </div>

    <div class="block">
      <h2>üìå Indications</h2>
      <ul>
        <li>Partial-onset seizures (adjunct therapy)</li>
        <li>Neuropathic pain associated with diabetic peripheral neuropathy</li>
        <li>Postherpetic neuralgia</li>
        <li>Fibromyalgia</li>
        <li>Generalized anxiety disorder (off-label in some countries)</li>
      </ul>
    </div>

    <div class="block">
      <h2>üíä Recommended Dose</h2>
      <h3>Adults</h3>
      <ul>
        <li><strong>Initial:</strong> 150 mg/day (in 2‚Äì3 divided doses)</li>
        <li><strong>Titration:</strong> Up to 300 mg/day after 1 week</li>
        <li><strong>Max:</strong> 600 mg/day</li>
      </ul>
      <h3>Children (‚â•1 month)</h3>
      <ul>
        <li><strong>‚â•30 kg:</strong> 2.5‚Äì10 mg/kg/day (max 600 mg/day)</li>
        <li><strong>&lt;30 kg:</strong> 3.5‚Äì14 mg/kg/day (max 600 mg/day)</li>
      </ul>
      <h3>Renal & Hepatic Adjustment</h3>
      <ul>
        <li><strong>Renal Impairment:</strong> Pregabalin is primarily eliminated by renal excretion. Dose adjustment is required based on CrCl:<br>
          ‚Ä¢ CrCl ‚â•60 mL/min: No modification required<br>
          ‚Ä¢ CrCl 30‚Äì60 mL/min: 50% of recommended dose<br>
          ‚Ä¢ CrCl 15‚Äì30 mL/min: 25% of recommended dose<br>
          ‚Ä¢ CrCl ‚â§15 mL/min: 8%‚Äì16% of recommended dose
        </li>
        <li><strong>Hepatic Impairment:</strong> No dosage adjustment necessary as pregabalin is minimally protein-bound and not significantly metabolized.</li>
      </ul>
    </div>
     <div class="block">
      <h2>üíâ Dosage Forms</h2>
      <table>
        <tr><th>Form</th><th>Strength</th></tr>
        <tr><td>Capsules</td><td>25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg</td></tr>
        <tr><td>Oral Solution</td><td>20 mg/mL</td></tr>
      </table>
    </div>


    <div class="block">
      <h2>‚öôÔ∏è Mechanism of Action</h2>
      <p>Pregabalin binds to the Œ±2-Œ¥ subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx at nerve terminals and subsequently decreasing the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P.</p>
    </div>

    <div class="block">
      <h2>üìä Pharmacokinetics</h2>
      <table>
        <tr><td>Absorption</td><td>Rapid, peak ~1 hr</td></tr>
        <tr><td>Bioavailability</td><td>‚â•90%</td></tr>
        <tr><td>Vd</td><td>~0.56 L/kg</td></tr>
        <tr><td>Protein Binding</td><td>&lt;1%</td></tr>
        <tr><td>Metabolism</td><td>Negligible</td></tr>
        <tr><td>Excretion</td><td>Renal (90% unchanged)</td></tr>
        <tr><td>Half-life</td><td>6.3 hrs</td></tr>
        <tr><td>Clearance</td><td>Proportional to creatinine clearance</td></tr>
      </table>
    </div>
<div class="block">
      <h2>‚õî Contraindications</h2>
      <p>Hypersensitivity to pregabalin or any component of the formulation</p>
    </div>

    <div class="block">
      <h2>‚ö†Ô∏è Side Effects</h2>
      <h3>Common</h3>
      <ul>
        <li>Dizziness, Somnolence, Dry mouth, Peripheral edema, Weight gain, Blurred vision</li>
      </ul>
      <h3>Major</h3>
      <ul>
        <li>Angioedema, Rhabdomyolysis, Suicidal ideation, Anaphylaxis, Myopathy</li>
      </ul>
      <h3>Rare</h3>
      <ul>
        <li>Cognitive issues, Euphoria, Thrombocytopenia, Diplopia, Stevens-Johnson syndrome</li>
      </ul>
    </div>

    

    <div class="block">
      <h2>üîÑ Interactions</h2>
      <p><strong>Drug-Drug:</strong> CNS depression with alcohol, opioids, BZDs. No major metabolic interactions.</p>
      <p><strong>Drug-Food:</strong> No significant effect</p>
      <p><strong>Drug-Disease:</strong> Adjust in renal impairment, caution in CHF or psychiatric history</p>
    </div>

    <div class="block">
      <h2>ü§∞ Pregnancy</h2>
      <p><strong>Category C:</strong>  Animal reproduction studies have shown adverse effects on the fetus;
         no adequate human studies. Use only if potential benefit justifies the risk..</p>
    </div>

    <div class="block">
      <h2>üö´ Off-Label Uses</h2>
      <ul>
        <li>GAD (approved in some countries)</li>
        <li>Alcohol withdrawal</li>
        <li>Restless legs syndrome</li>
        <li>Bipolar disorder</li>
        <li>Chronic cough</li>
      </ul>
    </div>

    <div class="block">
      <h2>‚è±Ô∏è Missed Dose</h2>
      <p>Take the missed dose as soon as you remember. However, if it‚Äôs almost time for your next dose, skip the missed dose and take the next one at the regular scheduled time.
         Do not take two doses at the same time to make up for the missed one.</p>
    </div>

    <div class="block">
      <h2>üè∑Ô∏è Brands Available in Pakistan</h2>
      <table>
        <tr><th>Brand</th><th>Strength</th><th>Dosage Form</th><th>Manufacturer</th><th>Logo</th></tr>
        <tr>
          <td>Lyrica</td>
          <td>25‚Äì300mg</td>
          <td>Capsules</td>
          <td>Pfizer</td>
          <td><img class="brand-img" src="https://static.shop-apotheke.com/images/D03872887-p1.jpg" alt="Lyrica"></td>
        </tr>
        <tr>
          <td>Zeegap</td>
          <td>25‚Äì150mg</td>
          <td>Capsules</td>
          <td>Hilton Pharmaceuticals</td>
          <td><img class="brand-img" src="https://mrmedicinemart.com/wp-content/uploads/2023/02/Zeegap-75mg-capsule.jpg" alt="Zeegap"></td>
        </tr>
        <tr>
          <td>Gabica</td>
          <td>50‚Äì300mg</td>
          <td>Capsules</td>
          <td>Getz Pharma</td>
          <td><img class="brand-img" src="https://khalidpharmacy.com/wp-content/uploads/2018/02/1_1520768095-768x768.png" alt="Gabica"></td>
        </tr>
      </table>
    </div>

    <div class="block">
      <h2>üìö References</h2>
      <ul>
        <li>üìò <a href="https://www.ema.europa.eu/en/documents/product-information/lyrica-epar-product-information_en.pdf" target="_blank">EMA Product Info</a></li>
        <li>üìò <a href="https://www.ncbi.nlm.nih.gov/books/NBK470341/#article-27618.s7" target="_blank">NCBI Monograph</a></li>
        <li>üìÑ <a href="https://pdf.hres.ca/dpd_pm/00039029.PDF" target="_blank">Canadian PDF Monograph</a></li>
        <li>üåê <a href="https://www.drugs.com/monograph/pregabalin.html" target="_blank">Drugs.com Overview</a></li>
        <li>üì∫ <a href="https://youtu.be/_a-dQ-mzddw?si=x48oG8iKJl5v_jAP" target="_blank">Video Summary</a></li>
        <li>üìÑ <a href="https://images.app.goo.gl/RkYSVadQgPPJ7uHs8" target="_blank">Brochure</a></li>
      </ul>
    </div>
  </main>
  <footer>
    &copy; 2025 Pregabalin | Designed professionally by Syed Hamza
  </footer>
</body>
</html>

    

        